Wat is de prijs voor Onward Medical N.V. (ONWD)

Het prijs van Onward Medical N.V. (ONWD) is $2.76

Wat is de marktkapitalisatie voor Onward Medical N.V. (ONWD)

Marktkapitalisatie voorOnward Medical N.V. (ONWD) is $128.99M

Onward Medical N.V. (ONWD) WPA

Onward Medical N.V. is a medical technology company dedicated to developing innovative therapies for spinal cord injuries, operating both within the Netherlands and internationally. Among its primary offerings is ARCEX, a non-invasive, external platform. This system incorporates a wearable stimulator and a wireless programmer, designed to restore or significantly enhance hand and arm motor function for individuals living with spinal cord injuries. Complementing this is ARCIM, an implantable platform. ARCIM features an implantable pulse generator and a lead positioned near the spinal cord, empowering individuals with chronic paralysis to regain the ability to stand and walk, often with minimal or no external assistance. The company is also currently advancing the Up-LIFT Trial, a clinical study evaluating the safety and efficacy of ARCEX Therapy in restoring strength and mobility in the upper extremities of those affected by spinal cord injury. Established in 2014, Onward Medical N.V. maintains its headquarters in Eindhoven, Netherlands.

Jaar	EPS	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

EPS

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	EPS	EPS-verschil	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Argenx SE ARGX.US	$27.74	-	NL
Moderna, Inc. MRNA.US	$-7.98	-	US
CSL Limited CSL.AX	$-5.29	-	AU
Lonza Group AG LONN.SW	-	-	CH

Bedrijf

EPS

EPS-verschil

Land

Vertex Pharmaceuticals Incorporated

VRTX.US

$17.32

Argenx SE

ARGX.US

$27.74

Moderna, Inc.

MRNA.US

$-7.98

CSL Limited

CSL.AX

$-5.29

Lonza Group AG

LONN.SW

Onward Medical N.V.

ONWD

Categorie